Literature DB >> 27192569

Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.

John Attanasio1, E John Wherry2.   

Abstract

Costimulatory and inhibitory receptors play a key role in regulating immune responses to infections. Recent translation of knowledge about inhibitory receptors such as CTLA-4 and PD-1 into the cancer clinic highlights the opportunities to manipulate these pathways to treat human disease. Studies in infectious disease have provided key insights into the specific roles of these pathways and the effects of their manipulation. Here, recent studies are discussed that have addressed how major inhibitory and costimulatory pathways play a role in regulating immune responses during acute and chronic infections. Mechanistic insights from studies of infectious disease provide opportunities to further expand our toolkit to treat cancer and chronic infections in the clinic.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27192569      PMCID: PMC4873956          DOI: 10.1016/j.immuni.2016.04.022

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  199 in total

1.  OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection.

Authors:  M Kopf; C Ruedl; N Schmitz; A Gallimore; K Lefrang; B Ecabert; B Odermatt; M F Bachmann
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

Review 2.  Immune inhibitory receptors.

Authors:  J V Ravetch; L L Lanier
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

3.  Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory.

Authors:  M Suresh; J K Whitmire; L E Harrington; C P Larsen; T C Pearson; J D Altman; R Ahmed
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

4.  The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands.

Authors:  Audrey L Kinter; Emily J Godbout; Jonathan P McNally; Irini Sereti; Gregg A Roby; Marie A O'Shea; Anthony S Fauci
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

5.  Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade.

Authors:  Shawn D Blackburn; Haina Shin; Gordon J Freeman; E John Wherry
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

6.  Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection.

Authors:  M Iwashiro; R J Messer; K E Peterson; I M Stromnes; T Sugie; K J Hasenkrug
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

7.  Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses.

Authors:  S O Andreasen; J E Christensen; O Marker; A R Thomsen
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

8.  Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection.

Authors:  M Kopf; A J Coyle; N Schmitz; M Barner; A Oxenius; A Gallimore; J C Gutierrez-Ramos; M F Bachmann
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

9.  Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection.

Authors:  R Brad Jones; Lishomwa C Ndhlovu; Jason D Barbour; Prameet M Sheth; Aashish R Jha; Brian R Long; Jessica C Wong; Malathy Satkunarajah; Marc Schweneker; Joan M Chapman; Gabor Gyenes; Bahareh Vali; Martin D Hyrcza; Feng Yun Yue; Colin Kovacs; Aref Sassi; Mona Loutfy; Roberta Halpenny; Desmond Persad; Gerald Spotts; Frederick M Hecht; Tae-Wook Chun; Joseph M McCune; Rupert Kaul; James M Rini; Douglas F Nixon; Mario A Ostrowski
Journal:  J Exp Med       Date:  2008-11-10       Impact factor: 14.307

10.  TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection.

Authors:  Glen M Chew; Tsuyoshi Fujita; Gabriela M Webb; Benjamin J Burwitz; Helen L Wu; Jason S Reed; Katherine B Hammond; Kiera L Clayton; Naoto Ishii; Mohamed Abdel-Mohsen; Teri Liegler; Brooks I Mitchell; Frederick M Hecht; Mario Ostrowski; Cecilia M Shikuma; Scott G Hansen; Mark Maurer; Alan J Korman; Steven G Deeks; Jonah B Sacha; Lishomwa C Ndhlovu
Journal:  PLoS Pathog       Date:  2016-01-07       Impact factor: 6.823

View more
  97 in total

Review 1.  PSGL-1: A New Player in the Immune Checkpoint Landscape.

Authors:  Roberto Tinoco; Dennis C Otero; Amy A Takahashi; Linda M Bradley
Journal:  Trends Immunol       Date:  2017-03-02       Impact factor: 16.687

Review 2.  Developing Cures: Targeting Ontogenesis in Cancer.

Authors:  Victor T G Lin; Hawley C Pruitt; Rajeev S Samant; Lalita A Shevde
Journal:  Trends Cancer       Date:  2017-01-27

3.  Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis.

Authors:  Christopher S Smillie; Moshe Biton; Jose Ordovas-Montanes; Keri M Sullivan; Grace Burgin; Daniel B Graham; Rebecca H Herbst; Noga Rogel; Michal Slyper; Julia Waldman; Malika Sud; Elizabeth Andrews; Gabriella Velonias; Adam L Haber; Karthik Jagadeesh; Sanja Vickovic; Junmei Yao; Christine Stevens; Danielle Dionne; Lan T Nguyen; Alexandra-Chloé Villani; Matan Hofree; Elizabeth A Creasey; Hailiang Huang; Orit Rozenblatt-Rosen; John J Garber; Hamed Khalili; A Nicole Desch; Mark J Daly; Ashwin N Ananthakrishnan; Alex K Shalek; Ramnik J Xavier; Aviv Regev
Journal:  Cell       Date:  2019-07-25       Impact factor: 41.582

4.  TFH cells depend on Tcf1-intrinsic HDAC activity to suppress CTLA4 and guard B-cell help function.

Authors:  Fengyin Li; Xin Zhao; Yali Zhang; Peng Shao; Xiaoke Ma; William J Paradee; Chengyu Liu; Jianmin Wang; Hai-Hui Xue
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-12       Impact factor: 11.205

Review 5.  Impact of infection on transplantation tolerance.

Authors:  Shuangjin Yu; Chang Su; Xunrong Luo
Journal:  Immunol Rev       Date:  2019-09-19       Impact factor: 12.988

6.  Expression and Clinical Significance of OX40 and OX40L mRNA in Hepatocellular Carcinoma.

Authors:  P Du; Z Wang; J Geng; Y Wang
Journal:  Bull Exp Biol Med       Date:  2021-03-13       Impact factor: 0.804

7.  Targeting the PSGL-1 pathway for immune modulation.

Authors:  Roberto Tinoco; Linda M Bradley
Journal:  Immunotherapy       Date:  2017-09       Impact factor: 4.196

Review 8.  Listening to each other: Infectious disease and cancer immunology.

Authors:  Russell E Vance; Michael J Eichberg; Daniel A Portnoy; David H Raulet
Journal:  Sci Immunol       Date:  2017-01-13

9.  Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis.

Authors:  Ila Datar; Miguel F Sanmamed; Jun Wang; Brian S Henick; Jungmin Choi; Ti Badri; Weilai Dong; Nikita Mani; Maria Toki; Luis D Mejías; Maria D Lozano; Jose Luis Perez-Gracia; Vamsidhar Velcheti; Matthew D Hellmann; Justin F Gainor; Kristen McEachern; David Jenkins; Konstantinos Syrigos; Katerina Politi; Scott Gettinger; David L Rimm; Roy S Herbst; Ignacio Melero; Lieping Chen; Kurt A Schalper
Journal:  Clin Cancer Res       Date:  2019-05-03       Impact factor: 12.531

Review 10.  Fighting Persistence: How Chronic Infections with Mycobacterium tuberculosis Evade T Cell-Mediated Clearance and New Strategies To Defeat Them.

Authors:  Laurisa Ankley; Sean Thomas; Andrew J Olive
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.